Amino acid residue at position 13 in HLA-DR beta chain plays a critical role in the development of Kaposi's sarcoma in AIDS patients

AIDS

Volumn 18, Issue 2, 2004, Pages 199-204

  Gayà, Antoni ^a,d,g   Esteve, Anna ^b   Casabona, Jordi ^b   McCarthy, Jeanette J ^c   Martorell, Jaume ^d   Schulz, Thomas F ^e   Whitby, Denise ^f  

^a Fundacio Banc Sang Teixits Illes B   (Spain)

^b HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

^c SAN DIEGO STATE UNIVERSITY   (United States)

^d HOSPITAL CLÍNIC   (Spain)

^e UNIVERSITY OF LIVERPOOL   (United Kingdom)

^f INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^g Fundacio Banc de Sang i Teixits   (Spain)

Author keywords

Antigen presentation; HIV; HLA DRB1; Human herpesvirus 8; Immune response

Indexed keywords

AMINO ACID; CD4 ANTIGEN; HLA DR ANTIGEN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; AGE DISTRIBUTION; ANTIGEN PRESENTATION; ANTIGEN SPECIFICITY; ARTICLE; BETA CHAIN; CASE CONTROL STUDY; CONTROLLED STUDY; DISEASE PREDISPOSITION; ENVIRONMENTAL FACTOR; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; HUMAN HERPESVIRUS 8; IMMUNE RESPONSE; IMMUNOFLUORESCENCE; INFECTION RISK; KAPOSI SARCOMA; MAJOR CLINICAL STUDY; PATHOPHYSIOLOGY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN FUNCTION; SEROLOGY; SEX RATIO; VIRUS TRANSMISSION;

EID: 1342332103     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-200401230-00008     Document Type: Article

References (35)

1. Centers for Disease Control (United States). Revision of the CDC Surveillance Case Definition for Acquired Immunodeficiency Syndrome. MMWR 1987, 36:(Suppl 1S):3S-15S.
2. Haverkos HW, Drotman PD. Prevalence of Kaposi's sarcoma among patients with AIDS. N Engl J Med 1985, 312:1518-1521.
3. Beral V, Peterman TA, Berkelman RL, Jaffe HW. Kaposi's sarcoma among persons with AIDS: a sexually transmitted infection? Lancet 1990, 335:123-128.
4. Chang Y, Cesarman E, Pessin MS, Lee F, Culpepper J, Knowles DM, et al. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science 1994, 266: 1865-1869.
5. Whitby D, Howard MR, Tenant-Flowers M, Brink NS, Copas A, Boshoff CH, et al. Detection of Kaposi sarcoma associated herpesvirus in peripheral blood of HIV-infected individuals and progression to Kaposi's sarcoma. Lancet 1995, 346:799-802.
6. Simpson GR, Schulz TF, Whitby D, Cook PM, Boshoff, CH, Rainbow L, et al. Prevalence of Kaposi's sarcoma associated herpesvirus infection measured by antibodies to recombinant capsid protein and latent immunofluorescence antigen. Lancet 1996, 348:1133-1138.
7. Gao SJ, Kinsgley LA, Hoover DR, Spira TJ, Rinaldo CR, Saah AJ, et al. Seroconversion to antibodies against Kaposi's sarcoma-associated Herpesvirus-related latent nuclear antigens before the development of Kaposi's sarcoma. N Engl J Med 1996, 335:233-241.
8. Renwick N, Halaby T, Weverling GJ, Dukers NHTM, Simpson GR, Coutinho RA, et al. Seroconversion for human herpesvirus 8 during HIV infection is highly predictive of Kaposi's sarcoma. AIDS 1998, 12:2481-2488.
9. Dukers NH, Renwick N, Prins M, Geskus RB, Schulz TF, Weverling GJ, et al. Risk factors for human herpesvirus 8 seropositivity and seroconversion in a cohort of homosexual men. Am J Epidemiol 2000, 151:213-224.
10. Martin JN, Ganem DE, Osmond DH, Page-Shafer KA, Macrae D, Kedes DH. Sexual transmission and the natural history of human herpesvirus 8 infection. N Engl J Med 1998, 338:948-954.
11. Jacobson LP, Jenkins FJ, Springer G, Munoz A, Shah KV, Phair J, et al. Interaction of human immunodeficiency virus type 1 and human herpesvirus type 8 infections on the incidence of Kaposi's sarcoma. J Infect Dis 2000, 181:1940-1949.
12. Gambús G, Bourboulia D, Esteve A, Lahoz R, Rodríguez C, Bolao F, et al. Prevalence and distribution of HHV-8 in different subpopulations, with and without HIV infection, in Spain. AIDS 2001, 15:1167-1174.
13. Thursz B, Kwiatkowski M, Allsop CE, Greenwood BM, Thomas HC, Hill AV. Association between an MHC class II allele and clearance of hepatitis B virus in the Gambia. N Engl J Med 1995, 332:1065-1069.
14. Hill AV, Allsopp CE, Kwiatkowski D, Anstey NM, Twumasi P, Rowe PA, et al. Common West African HLA antigens are associated with protection from severe malaria. Nature 1991, 352:595-600.
15. Jeffery KJ, Usuku K, Hall SE, Matsumoto W, Taylor GP, Procter J, et al. HLA alleles determine human T-lymphotropic virus-I (HTLV-I) proviral load and the risk of HTLV-I-associated myelopathy. Proc Natl Acad Sci USA 1999, 96: 3848-38453.
16. Kaslow RA, Carrington M, Apple R, Park L, Muñoz A, Saah AJ, et al. Influence of combinations of human major histocompatibility complex genes on the course of HIV-1 infection. Nature Med 1996, 2:405-411.
17. Contu L, Cerimele D, Pintus A, Cottoni F, La Nasa G. HLA and Kaposi's sarcoma in Sardinia. Tissue Antigens 1984, 23: 240-245.
18. Papasteriades C, Kaloterakis A, Filiotou A, Economidou J, Nicolis G, Trichopoulos D, et al. Histocompatibility antigens HLA-A, -B, -DR in Greek patients with Kaposi's sarcoma. Tissue Antigens 1984, 24:313-315.
19. Strichman-Almashanu L, Weltfriend S, Gideoni O, Friedman-Birnbaum R, Pollack S. No significant association between HLA antigens and classic Kaposi sarcoma: molecular analysis of 49 Jewish patients. J Clin Immunol 1995, 15:205-209.
20. Scorza-Smeraldi R, Fabio G, Lazzarin A, Eisera NB, Moroni M, Zanussi C. HLA associated susceptibility to acquired immunodeficiency syndrome in Italian patients with human-immunodeficiency-virus infection. Lancet 1986, 2:1187-1189.
21. Mann D, O'Donnell M, Blattner W, Goederr J. Analysis of HLA alloantigen frequencies in patients with HIV-1 related Kaposi's sarcoma. J Acquir Immune Defic Syndr 1990, 3:S51-S5.
22. Friedman-Kien, Alvin E, Laubenstein LJ, Rubenstein P, Buimovici-Klein E, Marmor M, et al. Disseminated Kaposi's sarcoma in homosexual men. Ann Intern Med 1982, 96:693-700.
23. Pollack MS, Safal B, Dupont B. HLA-DR5 and HLA-DR2 are susceptibility factors for acquired immunodeficiency syndrome with Kaposi's sarcoma in different ethnic subpopulations. Dis Markers 1983, 1:135.
24. Prince HE, Schroff RW, Ayoub G, Han S, Gottlieb MS, Fahey JL. HLA studies in acquired immunodeficiency syndrome patients with Kaposi's sarcoma. J Clin Immunol 1984, 4:242.
25. Klein MR, Keet IP, D'Amaro J, Bende RJ, Hekman A, Mesman B, et al. Associations between HLA frequencies and pathogenic features of human immunodeficiency virus type 1 infection in seroconverters from the Amsterdam cohort of homosexual men. J Infect Dis 1994, 169:1244-1249.
26. Centre d'Estudis Epidemiològics sobre la Sida de Catalunya (CEESCAT) (Spain). EURO-SHAKS: European Study on HIV Associated Kaposi's Sarcoma. Workshop Barcelona, June 1998. Barcelona: Generalitat de Catalunya, Departament de Sanitat i Seguretat Social, 1998. Document Tècnic CEESCAT, 8.
27. Casabona J, Gambús G, Vall M, Rodés A. Risk factors for AIDS associated Kaposi's sarcoma. Pathol Oncol Res 1997, 3:74-77.
28. CDC. 1993 Revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR 1992, 41(no. RR-17).
29. Svejgaard A, Ryder LP. HLA and disease associations: Detecting the strongest association. Tissue Antigens 1994, 43:18-27.
30. Tiwari JL, Terasaki PI. HLA and Disease Associations. New York: Springer-Verlag; 1985.
31. Rosenberg ES, Billingsley JM, Caliendo AM, Boswell SL, Sax PE, Kalams SA, et al. Vigorous HIV-1 specific CD4+ T cell responses associated with control of viremia. Science 1997, 278: 447-1450.
32. Stern LJ, Brown JH, Jardetzky TS, Gorga JC, Urban RG, Strominger JL, et al. Crystal structure of the human class II MHC protein HLA-DR1 complexed with an influenza virus peptide. Nature 1994, 368:215-221.
33. Tsuji K, Aizawa M, Sasazuki T, eds. HLA 1991. New York: Oxford University Press; 1992.
34. Buchbinder S, Holmberg S, Scheer S. Effect of highly active antiretroviral therapy on the incidence of AIDS-related malignancies. J Acquir Immune Defic Syndr 1999, (Suppl 1):S23-S6.
35. Sparano JA, Anand K, Desai J, Mitnick RJ, Kalkut GE. Effect of highly active antiretroviral therapy on the incidence of HIV-associated malignancies at an urban medical center. J Acquir Defic Syndr 1999, 21:S18-S22.